Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 113 entries
View as:

Validation of a PrCr Dipstick Diagnostic Test in Ghana

Phase: N/A Priority: Normal
NCT ID: NCT03510286 Org: User:
Start: 09/30/18 End: 07/30/20 Due: 07/30/21

Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda

Phase: N/A Priority: Normal
NCT ID: NCT05462509 Org: User:
Start: 10/04/21 End: 12/15/21 Due: 12/15/22

Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

Phase: N/A Priority: Normal
NCT ID: NCT04010695 Org: User:
Start: 05/13/19 End: 09/19/19 Due: 09/19/20

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT02097472 Org: User:
Start: 04/30/14 End: 12/31/15 Due: 12/31/16

Comparative Safety Study of Two Vaginal Applicators With Tenofovir

Phase: N/A Priority: Normal
NCT ID: NCT01283555 Org: User:
Start: 01/31/11 End: 06/30/11 Due: 06/30/12

A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT01797029 Org: User:
Start: 02/28/13 End: 09/30/14 Due: 09/30/15

Dose Escalating Study of Intramuscular Invaplex[AR-DETOX]

Phase: N/A Priority: Normal
NCT ID: NCT03869333 Org: User:
Start: 03/18/19 End: 06/12/20 Due: 06/12/21

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

Phase: N/A Priority: Normal
NCT ID: NCT02308540 Org: User:
Start: 01/12/15 End: 11/03/16 Due: 11/03/17

MaCRA Part B in Nigeria

Phase: N/A Priority: Normal
NCT ID: NCT06805110 Org: User:
Start: 04/30/25 End: 09/30/25 Due: 09/30/26

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Mozambique

Phase: N/A Priority: Normal
NCT ID: NCT04716387 Org: User:
Start: 08/18/20 End: 09/30/22 Due: 09/30/23

Attractive Targeted Sugar Bait Phase III Trial in Zambia

Phase: N/A Priority: Normal
NCT ID: NCT04800055 Org: User:
Start: 12/01/20 End: 12/31/23 Due: 12/31/24

Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01567865 Org: User:
Start: 05/31/12 End: 12/31/12 Due: 12/31/13

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

Phase: N/A Priority: Normal
NCT ID: NCT00524745 Org: User:
Start: 10/31/07 End: 01/31/10 Due: 01/31/11

Coadministration of Measles-rubella and Rotavirus Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01700621 Org: User:
Start: 01/31/13 End: 09/30/13 Due: 09/30/14

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Phase: N/A Priority: Normal
NCT ID: NCT06129916 Org: User:
Start: 11/01/24 End: 12/31/26 Due: 12/31/27

A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.

Phase: N/A Priority: Normal
NCT ID: NCT05614388 Org: User:
Start: 12/31/22 End: 05/31/23 Due: 05/31/24

Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Mozambique

Phase: N/A Priority: Normal
NCT ID: NCT04724161 Org: User:
Start: 12/09/20 End: 09/30/22 Due: 09/30/23

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT02165202 Org: User:
Start: 10/31/14 End: 03/09/17 Due: 03/09/18

A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra Leone

Phase: N/A Priority: Normal
NCT ID: NCT06395207 Org: User:
Start: 05/06/24 End: 03/30/25 Due: 03/30/26

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01511419 Org: User:
Start: 04/30/12 End: 07/31/12 Due: 07/31/13

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT06137664 Org: User:
Start: 11/20/24 End: 12/15/27 Due: 12/15/28

Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Phase: N/A Priority: Normal
NCT ID: NCT01575197 Org: User:
Start: 09/30/12 End: 02/28/13 Due: 02/28/14

Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03038243 Org: User:
Start: 08/01/17 End: 12/31/19 Due: 12/31/20

Evaluation of Different G6PD Testing Platforms

Phase: N/A Priority: Normal
NCT ID: NCT02104518 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02434770 Org: User:
Start: 08/31/15 End: 06/17/16 Due: 06/17/17